Weizmannia coagulans BCF-01: a novel gastrogenic probiotic for Helicobacter pylori infection control

References

• Crowe SE. Helicobacter pylori Infection. N Engl J Med. 2019;380(12):1158–18. doi:10.1056/NEJMcp1710945.
   PubMed Web of Science ®Google Scholar
• Zavros Y, Merchant JL. The immune microenvironment in gastric adenocarcinoma. Nat Rev Gastroenterol Hepatol. 2022;19(7):451–467. doi:10.1038/s41575-022-00591-0.
   PubMed Web of Science ®Google Scholar
• Li Y, Choi H, Leung K, Jiang F, Graham DY, Leung WK. Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(6):553–564. doi:10.1016/S2468-1253(23)00070-5.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Nadatani Y, Suda W, Higashimori A, Otani K, Fukunaga S, Hosomi S, Tanaka F, Nagami Y, Taira K. et al. Long-term persistence of gastric dysbiosis after eradication of Helicobacter pylori in patients who underwent endoscopic submucosal dissection for early gastric cancer. Gastric Cancer. 2021;24(3):710–720. doi:10.1007/s10120-020-01141-w.
   PubMed Web of Science ®Google Scholar
• Noto JM, Zackular JP, Varga MG, Delgado A, Romero-Gallo J, Scholz MB, Piazuelo MB, Skaar EP, Peek RM Jr. Modification of the Gastric Mucosal Microbiota by a Strain-Specific Helicobacter pylori Oncoprotein and Carcinogenic Histologic Phenotype. mBio. 2019;10(3):10–128. doi:10.1128/mBio.00955-19.
   Web of Science ®Google Scholar
• Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, Jones NL, Render C, Leontiadis GI, Moayyedi P. et al. The Toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology. 2016;151(1):51–69.e14. doi:10.1053/j.gastro.2016.04.006.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, Gasbarrini A, Hunt RH, Leja M, O’Morain C. et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022;71(9):1724–1762. doi:10.1136/gutjnl-2022-327745.
   Web of Science ®Google Scholar
• Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization Regions. Gastroenterology. 2018;155(5):1372–1382.e17. doi:10.1053/j.gastro.2018.07.007.
   PubMed Web of Science ®Google Scholar
• Liou JM, Chen CC, Chang CM, Fang YJ, Bair MJ, Chen PY, Chang CY, Hsu YC, Chen MJ, Chen CC. et al. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial. Lancet Infect Dis. 2019;19(10):1109–1120. doi:10.1016/S1473-3099(19)30272-5.
   PubMed Web of Science ®Google Scholar
• Wang ZJ, Chen XF, Zhang ZX, Li YC, Deng J, Tu J, Song ZQ, Zou QH. Effects of anti-Helicobacter pylori concomitant therapy and probiotic supplementation on the throat and gut microbiota in humans. Microb Pathogen. 2017;109:156–161. doi:10.1016/j.micpath.2017.05.035.
   PubMed Web of Science ®Google Scholar
• Zhu XY, Liu F. Probiotics as an adjuvant treatment in Helicobacter pylori eradication therapy. J Digest Dis. 2017;18(4):195–202. doi:10.1111/1751-2980.12466.
   PubMed Web of Science ®Google Scholar
• Fang HR, Zhang GQ, Cheng JY, Li ZY. Efficacy of Lactobacillus-supplemented triple therapy for Helicobacter pylori infection in children: a meta-analysis of randomized controlled trials. Eur J Pediatr. 2019;178(1):7–16. doi:10.1007/s00431-018-3282-z.
   PubMed Web of Science ®Google Scholar
• Tang B, Tang L, Huang C, Tian C, Chen L, He Z, Yang G, Zuo L, Zhao G, Liu E. et al. The effect of probiotics supplementation on gut microbiota after Helicobacter pylori eradication: a multicenter randomized controlled trial. Infect Dis Ther. 2021;10(1):317–333. doi:10.1007/s40121-020-00372-9.
   PubMed Web of Science ®Google Scholar
• McNicholl AG, Molina-Infante J, Lucendo AJ, Calleja JL, Pérez-Aisa Á, Modolell I, Aldeguer X, Calafat M, Comino L, Ramas M. et al. Probiotic supplementation with lactobacillus plantarum and pediococcus acidilactici for Helicobacter pylori therapy: a randomized, double-blind, placebo-controlled trial. Helicobacter. 2018;23(5):e12529. doi:10.1111/hel.12529.
   PubMed Web of Science ®Google Scholar
• Chen MJ, Chen CC, Huang YC, Tseng CC, Hsu JT, Lin YF, Fang YJ, Wu MS, Liou JM. The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota-a double-blind, placebo-controlled, randomized trial. Helicobacter. 2021;26(6):e12857. doi:10.1111/hel.12857.
   PubMed Web of Science ®Google Scholar
• Chen Z, Chen H, Yu L, Xin H, Kong J, Bai Y, Zeng W, Zhang J, Wu Q, Fan H. Bioinformatic identification of key pathways, hub genes, and microbiota for therapeutic intervention in Helicobacter pylori infection. J Cell Physiol. 2021;236(2):1158–1183. doi:10.1002/jcp.29925.
   PubMed Web of Science ®Google Scholar
• Kang S, Park MY, Brooks I, Lee J, Kim SH, Kim JY, Oh B, Kim JW, Kwon O. Spore-forming Bacillus coagulans SNZ 1969 improved intestinal motility and constipation perception mediated by microbial alterations in healthy adults with mild intermittent constipation: a randomized controlled trial. Food Res Int. 2021;146:110428. doi:10.1016/j.foodres.2021.110428.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Fujiwara Y, Thongbhubate K, Maeda M, Kanaori K. Spore-Forming Lactic Acid-Producing Bacterium Bacillus coagulans Synthesizes and Excretes Spermidine into the Extracellular Space. J Agr Food Chem. 2023;71(25):9868–9876. doi:10.1021/acs.jafc.3c02184.
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiang Z, Zhang Z, Liu T, Fan Y, Liu T, Peng N, Claesen J. Bacillus coagulans in combination with chitooligosaccharides regulates gut microbiota and ameliorates the DSS-Induced colitis in mice. Microbiol Spectr. 2022;10(4):e0064122. doi:10.1128/spectrum.00641-22.
   PubMed Web of Science ®Google Scholar
• Sudha MR, Jayanthi N, Aasin M, Dhanashri RD, Anirudh T. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study. Beneficial Microbes. 2018;9(4):563–572. doi:10.3920/BM2017.0129.
   PubMed Web of Science ®Google Scholar
• Holz C, Busjahn A, Mehling H, Arya S, Boettner M, Habibi H, Lang C. Significant reduction in Helicobacter pylori load in Humans with Non-viable Lactobacillus reuteri DSM17648: a Pilot study. Probiotics & Antimicro Prot. 2015;7(2):91–100. doi:10.1007/s12602-014-9181-3.
   PubMed Web of Science ®Google Scholar
• Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10(10):996–998. doi:10.1038/nmeth.2604.
   PubMed Web of Science ®Google Scholar
• Chen T, Liu YX, Huang L. ImageGP: an easy-to-use data visualization web server for scientific researchers. iMeta. 2022;1(1):e5. doi:10.1002/imt2.5.
   Google Scholar
• Malfertheiner P, Camargo MC, El-Omar E, Liou JM, Peek R, Schulz C, Smith SI, Suerbaum S. Helicobacter pylori infection. Nat Rev Dis Primers. 2023;9(1):19. doi:10.1038/s41572-023-00431-8.
   PubMed Web of Science ®Google Scholar
• Leshem A, Liwinski T, Elinav E. Immune-Microbiota Interplay and Colonization Resistance in Infection. Mol Cell. 2020;78(4):597–613. doi:10.1016/j.molcel.2020.03.001.
   PubMed Web of Science ®Google Scholar
• Jin S, Nepal N, Gao Y. The role of toll-like receptors in peptic ulcer disease. Immunol Med. 2022;45(2):69–78. doi:10.1080/25785826.2021.1963190.
   PubMedGoogle Scholar
• Yang T, Wang R, Liu H, Wang L, Li J, Wu S, Chen X, Yang X, Zhao Y. Berberine regulates macrophage polarization through IL-4-STAT6 signaling pathway in Helicobacter pylori-induced chronic atrophic gastritis. Life Sci. 2021;266:118903. doi:10.1016/j.lfs.2020.118903.
   PubMed Web of Science ®Google Scholar
• Koretz RL. Probiotics in gastroenterology: how pro is the evidence in adults? American J Gastroenterol. 2018;113(8):1125–1136. doi:10.1038/s41395-018-0138-0.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gu Z, Zhang S, Li P. Complete genome sequencing revealed the potential application of a novel Weizmannia coagulans PL-W production with promising bacteriocins in food preservative. Foods (Basel, Switzerland). 2023;12(1):216. doi:10.3390/foods12010216.
   PubMed Web of Science ®Google Scholar
• Mu Y, Cong Y. Bacillus coagulans and its applications in medicine. Benef Microbes. 2019;10(6):679–688. doi:10.3920/BM2019.0016.
   PubMed Web of Science ®Google Scholar
• Gao Y, Yu T, Ai F, Ji C, Wu Y, Huang X, Zheng X, Yan F. Bacillus coagulans XY2 ameliorates copper-induced toxicity by bioadsorption, gut microbiota and lipid metabolism regulation. J Hazardous Materials. 2023;445:130585. doi:10.1016/j.jhazmat.2022.130585.
   PubMed Web of Science ®Google Scholar
• Gao Y, Yu T, Wu Y, Huang X, Teng J, Zhao N, Zheng X, Yan F. Bacillus coagulans (Weizmannia coagulans) XY2 attenuates Cu-induced oxidative stress via DAF-16/FoxO and SKN-1/Nrf2 pathways and gut microbiota regulation. J Hazardous Materials. 2023;457:131741. doi:10.1016/j.jhazmat.2023.131741.
   PubMed Web of Science ®Google Scholar
• Tshibangu-Kabamba E, Yamaoka Y. Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications. Nat Rev Gastroenterol Hepatol. 2021;18(9):613–629. doi:10.1038/s41575-021-00449-x.
   PubMed Web of Science ®Google Scholar
• Zhang J, Guo J, Li D, Chen M, Liu J, Feng C, He Q, Zhao J, Zhang L, Chen J. et al. The efficacy and safety of Clostridium butyricum and bacillus coagulans in Helicobacter pylori eradication treatment: an open-label, single-arm pilot study. Med. 2020;99(45):e22976. doi:10.1097/MD.0000000000022976.
   PubMed Web of Science ®Google Scholar
• Xing SC, Chen JY, Lv N, Mi JD, Chen WL, Liang JB, Liao XD. Biosorption of lead (Pb(2+)) by the vegetative and decay cells and spores of Bacillus coagulans R11 isolated from lead mine soil. Chemosphere. 2018;211:804–816. doi:10.1016/j.chemosphere.2018.08.005.
   PubMed Web of Science ®Google Scholar
• Ma S, Cao J, Liliu R, Li N, Zhao J, Zhang H, Chen W, Zhai Q. Effects of bacillus coagulans as an adjunct starter culture on yogurt quality and storage. J Dairy Sci. 2021;104(7):7466–7479. doi:10.3168/jds.2020-19876.
   PubMed Web of Science ®Google Scholar
• Chaudhari K, Mohan M, Saudagar P, Sable C, Shinde S, Bedade D. In vitro and in vivo evaluation of probiotic potential and safety assessment of Bacillus coagulans SKB LAB-19 (MCC 0554) in humans and animal healthcare. Regul Toxicol Pharmacol. 2022;133:105218. doi:10.1016/j.yrtph.2022.105218.
   PubMed Web of Science ®Google Scholar
• Bang WY, Ban OH, Lee BS, Oh S, Park C, Park MK, Jung SK, Yang J, Jung YH. Genomic-, phenotypic-, and toxicity-based safety assessment and probiotic potency of Bacillus coagulans IDCC 1201 isolated from green malt. J Ind Microbiol Biotechnol. 2021;48(5–6):kuab026. doi:10.1093/jimb/kuab026.
   PubMed Web of Science ®Google Scholar
• Majeed M, Nagabhushanam K, Natarajan S, Sivakumar A, Eshuis-de Ruiter T, Booij-Veurink J, de Vries YP, Ali F. Evaluation of genetic and phenotypic consistency of bacillus coagulans MTCC 5856: a commercial probiotic strain. World J Microbiol Biotechnol. 2016;32(4):60. doi:10.1007/s11274-016-2027-2.
   PubMed Web of Science ®Google Scholar
• Kesavelu D Sr. The efficacy and safety of combined Senna and probiotic-based bowel preparation for colonoscopy in children. Cureus. 2020;12(9):e10180. doi:10.7759/cureus.10180.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Sun M, Cui X, Chen J, Liu C, Zhang X. Bacillus coagulans MZY531 alleviates intestinal mucosal injury in immunosuppressive mice via modulating intestinal barrier, inflammatory response, and gut microbiota. Sci Rep. 2023;13(1):11181. doi:10.1038/s41598-023-38379-0.
   PubMed Web of Science ®Google Scholar